The value of desmosomal plaque-related markers to distinguish squamous cell carcinoma and adenocarcinoma of the lung

References

• Boyle P, Levin B. World cancer report 2008. Lyon, France: International Agency for Research on Cancer; 2008.
   Google Scholar
• Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG, editors. WHO classification of tumours of lung, pleura, thymus and hearth, 4th ed. Lyon: IARC; 2015.
   Google Scholar
• Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to the 2015 WHO classification of tumors of lung, pleura, thymus and heart. J Thorac Oncol. 2015;10:1240–2. doi:10.1097/JTO.0000000000000663
   PubMed Web of Science ®Google Scholar
• Hirsch FR, Spreafico A, Novello S, Wood MD, Simms L, Papotti M. The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review. J Thorac Oncol. 2008;3:1468–81. doi:10.1097/JTO.0b013e318189f551
   PubMed Web of Science ®Google Scholar
• Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus permetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol. 2008;26:3543–51. doi:10.1200/JCO.2007.15.0375
   PubMed Web of Science ®Google Scholar
• Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, et al. Spanish Lung Cancer Group. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med. 2009;361:958–67. doi:10.1056/NEJMoa0904554
   PubMed Web of Science ®Google Scholar
• Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, Maki RG, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med. 2010;363:1693–703. doi:10.1056/NEJMoa1006448
   PubMed Web of Science ®Google Scholar
• Azzoli CG, Baker S, Jr, Temin S, Pao W, Aliff T, Brahmer J, et al. American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer. Jco. 2009;27:6251–66. doi:10.1200/JCO.2009.23.5622
   PubMed Web of Science ®Google Scholar
• Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, et al. American Thoracic Society. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc. 2011;8:381–5. doi:10.1513/pats.201107-042ST
   PubMedGoogle Scholar
• Loo PS, Thomas SC, Nicolson MC, Fyfe MN, Kerr KM. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens. J Thorac Oncol. 2010; 5:442–7. doi:10.1097/JTO.0b013e3181d40fac
   PubMed Web of Science ®Google Scholar
• Nicholson AG, Gonzalez D, Shah P, Pynegar MJ, Deshmukh M, Rice A, et al. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis. J Thorac Oncol. 2010;54:436–41. doi:10.1097/JTO.0b013e3181c6ed9b
   Web of Science ®Google Scholar
• Schmidt A, Jäger S. Plakophilins – hard work in the desmosome, recreation in the nucleus? Eur J Cell Biol. 2005;84:189–204. doi:10.1016/j.ejcb.2004.12.020
   PubMed Web of Science ®Google Scholar
• Hatzfeld M. Plakophilins: multifunctional proteins or just regulators of desmosomal adhesion? Biochim Biophys Acta. 2007;1773:69–77. doi:10.1016/j.bbamcr.2006.04.009
   PubMed Web of Science ®Google Scholar
• Bass-Zubek AE, Godsel LM, Delmar M, Green KJ. Plakophilins: multifunctional scaffolds for adhesion and signaling. Curr Opin Cell Biol. 2009;21:708–16. doi:10.1016/j.ceb.2009.07.002
   PubMed Web of Science ®Google Scholar
• Kowalczyk AP, Green KJ. Structure, function, and regulation of desmosomes. Prog Mol Biol Transl Sci. 2013;116:95–118. doi:10.1016/B978-0-12-394311-8.00005-4
   PubMed Web of Science ®Google Scholar
• Hatzfeld M, Wolf A, Keil R. Plakophilins in desmosomal adhesion and signaling. Cell Commun Adhes. 2014;21:25–42. doi:10.3109/15419061.2013.876017
   PubMed Web of Science ®Google Scholar
• Wolf A, Rietscher K, Glass M, Hüttelmaier S, Schutkowski M, Ihling C, et al. Insulin signaling via Akt2 switches plakophilin 1 function from stabilizing cell adhesion to promoting cell proliferation. J Cell Sci. 2013;126:1832–44. doi:10.1242/jcs.118992
   PubMed Web of Science ®Google Scholar
• Sobolik-Delmaire T, Reddy R, Pashaj A, Roberts BJ, Wahl JK. 3rd., Plakophilin-1 localizes to the nucleus and interacts with single-stranded DNA. J Investig Dermatol. 2010;130:2638–46. doi:10.1038/jid.2010.191
   PubMed Web of Science ®Google Scholar
• Daniel JM, Reynolds AB. The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol. 1999;19:3614–23. doi:10.1128/MCB.19.5.3614
   PubMed Web of Science ®Google Scholar
• Grossmann KS, Grund C, Huelsken J, Behrend M, Erdmann B, Franke WW, et al. Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation. J Cell Biol. 2004;167:149–60. doi:10.1083/jcb.200402096
   PubMed Web of Science ®Google Scholar
• Chen X, Bonne S, Hatzfeld M, van Roy F, Green KJ. Protein binding and functional characterization of Plakophilin 2. Evidence for its diverse roles in Desmosomes and beta-catenin signaling. J Biol Chem. 2002;277:10512–22. doi:10.1074/jbc.M108765200
   PubMed Web of Science ®Google Scholar
• Brown L, Wan H. Desmoglein 3: a help or a hindrance in cancer progression?. Cancers 2015;7:266–86. doi:10.3390/cancers7010266
   PubMed Web of Science ®Google Scholar
• Bose A, Teh MT, Mackenzie IC, Waseem A. Keratin k15 as a biomarker of epidermal stem cells. Ijms. 2013;14:19385–98. doi:10.3390/ijms141019385
   Web of Science ®Google Scholar
• Sanchez-Palencia A, Gomez-Morales M, Gomez-Capilla JA, Pedraza V, Boyero L, Rosell R, et al. Gene expression profiling reveals novel biomarkers in non-small cell lung cancer. Int J Cancer. 2011;129:355–64. doi:10.1002/ijc.25704
   PubMed Web of Science ®Google Scholar
• Gomez-Morales M, Camara-Pulido M, Miranda-Leon MT, Sánchez-Palencia A, Boyero L, Gómez-Capilla JA, et al. Differential immunohistochemical localization of desmosomal plaque-related proteins in non-small-cell lung cancer. Histopathology 2013;63:103–13. doi:10.1111/his.12126
   PubMed Web of Science ®Google Scholar
• Kim MJ, Shin HC, Shin KC, Ro JY. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens. Ann Diagn Pathol. 2013;17:85–90. doi:10.1016/j.anndiagpath.2012.07.006
   PubMed Web of Science ®Google Scholar
• Whithaus K, Fukuoka J, Prihoda TJ, Jagirdar J. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. Arch Pathol Lab Med. 2012;136:155–62. doi:10.5858/arpa.2011-0232-OA
   PubMed Web of Science ®Google Scholar
• Sheikh HA, Fuhrer K, Cieply K, Yousem S. p63 expression in assessment of bronchioloalveolar proliferations of the lung. Mod Pathol. 2004;17:1134–40. doi:10.1038/modpathol.3800163
   PubMed Web of Science ®Google Scholar
• Kadota K, Nitadori J, Rekhtman N, Jones DR, Adusumilli PS, Travis WD. Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis. Am J Surg Pathol. 2015;39:1170–80. doi:10.1097/PAS.0000000000000439
   PubMed Web of Science ®Google Scholar
• Agackiran Y, Ozcan A, Akyurek N, Memis L, Findik G, Kaya S. Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes. Appl Immunohistochem Mol Morphol. 2012;20:350–5. doi:10.1097/PAI.0b013e318245c730
   PubMedGoogle Scholar
• Savci-Heijink CD, Kosari F, Aubry MC, Caron BL, Sun Z, Yang P, et al. The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung. Am J Pathol. 2009;174:1629–37. doi:10.2353/ajpath.2009.080778
   PubMed Web of Science ®Google Scholar
• Koh J, Go H, Kim MY, Jeon YK, Chung JH, Chung DH. A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers. Histopathology. 2014;65:868–78. doi:10.1111/his.12507
   PubMed Web of Science ®Google Scholar
• Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710–7. doi:10.1378/chest.111.6.1710
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Katzenstein AL. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am J Surg Pathol. 2011;35:15–25. doi:10.1097/PAS.0b013e3182036d05
   PubMed Web of Science ®Google Scholar
• Terry J, Leung S, Laskin J, Leslie KO, Gown AM, Ionescu DN. Optimal immunohistochemical markers for distinguishing lung adenocarcinoma from squamous cell carcinomas in small tumor samples. Am J Surg Pathol. 2010;34:1805–11. doi:10.1097/PAS.0b013e3181f7dae3
   PubMed Web of Science ®Google Scholar
• Tacha D, Zhou D, Henshall-Powell RL. Distinguishing adenocarcinoma from squamous cell carcinoma in lung using double stains p63+ CK5 and TTF-1 + Napsin A. Mod Pathol. 2010;23:222A.
   Google Scholar
• Tacha D, Yu CH, Haas T. TTF-1, Napsin A, p63, TRIM29, Desmoglein 3 and CK5: an evaluation of sensitivity and specificity and correlation of tumor grade for lung cell carcinoma vs. lung adenocarcinoma. Mod Pathol. 2011;24:425A.
   PubMed Web of Science ®Google Scholar
• Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, et al. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med. 2013;137:668–84. doi:10.5858/arpa.2012-0263-RA
   PubMed Web of Science ®Google Scholar
• Bishop JA, Teruya-Feldstein J, Westra WH, Pelosi G, Travis WD, Rekhtman N. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol. 2012;25:405–15. doi:10.1038/modpathol.2011.173
   PubMed Web of Science ®Google Scholar
• Pelosi G, Fabbri A, Bianchi F, Maisonneuve P, Rossi G, Barbareschi M, et al. ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach. J Thorac Oncol. 2012;7:281–90. doi:10.1097/JTO.0b013e31823815d3
   PubMed Web of Science ®Google Scholar
• Matoso A, Singh K, Jacob R, Greaves WO, Tavares R, Noble L, et al. Comparison of thyroid transcription factor-1 expression by two monoclonal antibodies in pulmonary and non-pulmonary primary tumors. Appl Immunohistochem Mol Morphol. 2010;18:142–9. doi:10.1097/PAI.0b013e3181bdf4e7
   PubMedGoogle Scholar
• Inamura K. Update on immunohistochemistry for the diagnosis of lung cancer. Cancers. 2018;10:72. doi:10.3390/cancers10030072
   PubMed Web of Science ®Google Scholar
• Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. Mod Pathol. 2011;24:1348–59. doi:10.1038/modpathol.2011.92
   PubMed Web of Science ®Google Scholar
• Hobbs RP, Jacob JT, Coulombe PA. Keratins are going nuclear. Dev Cell. 2016;38:227–33. doi:10.1016/j.devcel.2016.07.022
   PubMed Web of Science ®Google Scholar